Ticker
LPCNCompany Name
LIPOCINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 18.58M | $ 6.04M | 32.53% |
3/31/2025 | $ 20.5M | $ 3.35M | 16.36% |
12/31/2024 | $ 22.51M | $ 6.21M | 27.57% |
9/30/2024 | $ 20.7M | $ 3.74M | 18.08% |
6/30/2024 | $ 23.03M | $ 5.55M | 24.11% |
3/31/2024 | $ 25.45M | $ 3.08M | 12.11% |
12/31/2023 | $ 23M | $ 4.77M | 20.75% |
9/30/2023 | $ 24.75M | $ 4.07M | 16.45% |
6/30/2023 | $ 30.48M | $ 5.01M | 16.45% |
3/31/2023 | $ 34.02M | $ 4.77M | 14.02% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for LIPOCINE INC is calculated as follows: CashnEq [ $ 17.94M ] / Assets [ $ 24.75M ]
(=) Cash to Assets [ 72.47% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |